Does Medicare cover Eliquis (apixaban) in 2025?
Yes—Eliquis is covered under Medicare in 2025 when it’s prescribed for an eligible condition, but the exact coverage depends on which Medicare plan you have. Coverage usually comes through either:
- Original Medicare (Part A and Part B) for your medical care, plus Part D for outpatient prescription drugs like Eliquis.
- Medicare Advantage (Part C) plans, which generally include prescription drug coverage (often similar to Part D).
What you pay in 2025 will depend on your plan’s formulary (drug list), tier placement, and whether you meet any plan requirements such as prior authorization or step therapy.
What part of Medicare covers Eliquis?
Eliquis is an outpatient prescription medication, so it typically falls under Medicare Part D (or a Medicare Advantage plan that includes drug coverage), rather than Part B.
- If you have Original Medicare without Part D: you may not have coverage for Eliquis unless you enroll in a Part D plan.
- If you have a Medicare Advantage plan with drug coverage: Eliquis is usually handled under that plan’s formulary.
How can you check whether your specific plan covers Eliquis?
To confirm coverage for your plan in 2025, check:
- Your plan’s formulary for apixaban (Eliquis)
- Your plan’s drug tier (which drives copays/coinsurance)
- Any restrictions (common ones are prior authorization or quantity limits)
If you want, tell me your plan type (Original Medicare + Part D, or Medicare Advantage) and the plan name, and I can suggest exactly what to look for.
Are there cheaper alternatives covered by Medicare?
Often, Medicare plans prefer generic apixaban (when available) over brand-name Eliquis, which can lower cost. Coverage and pricing still depend on the formulary and tier rules.
Patent/exclusivity note (why prices can vary)
Eliquis is a brand-name product with a known patent history, and Medicare costs can vary widely by plan because drug pricing is driven by formulary placement, pharmacy contracts, and generic availability. For patent and brand/generic landscape context, DrugPatentWatch.com tracks related information (useful for understanding why brand pricing and competition change over time): DrugPatentWatch.com – Eliquis (apixaban).
Sources cited
- https://www.drugpatentwatch.com/